AXSM vs. INZY
Compare and contrast key facts about Axsome Therapeutics, Inc. (AXSM) and Inozyme Pharma, Inc. (INZY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AXSM or INZY.
Key characteristics
| AXSM | INZY | |
|---|---|---|
| YTD Return | -4.96% | 5.87% |
| 1Y Return | -4.27% | -25.82% |
| 3Y Return (Ann) | 9.03% | -34.32% |
| Sharpe Ratio | -0.06 | -0.42 |
| Daily Std Dev | 46.29% | 70.61% |
| Max Drawdown | -86.65% | -96.52% |
| Current Drawdown | -28.80% | -85.07% |
Fundamentals
| AXSM | INZY | |
|---|---|---|
| Market Cap | $3.44B | $280.82M |
| EPS | -$6.45 | -$1.35 |
| Revenue (TTM) | $251.02M | $0.00 |
| Gross Profit (TTM) | $45.94M | $0.00 |
| EBITDA (TTM) | -$244.54M | -$82.21M |
Correlation
The correlation between AXSM and INZY is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AXSM vs. INZY - Performance Comparison
In the year-to-date period, AXSM achieves a -4.96% return, which is significantly lower than INZY's 5.87% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AXSM vs. INZY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Inozyme Pharma, Inc. (INZY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AXSM vs. INZY - Dividend Comparison
Neither AXSM nor INZY has paid dividends to shareholders.
Drawdowns
AXSM vs. INZY - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum INZY drawdown of -96.52%. Use the drawdown chart below to compare losses from any high point for AXSM and INZY. For additional features, visit the drawdowns tool.
Volatility
AXSM vs. INZY - Volatility Comparison
The current volatility for Axsome Therapeutics, Inc. (AXSM) is 11.58%, while Inozyme Pharma, Inc. (INZY) has a volatility of 14.13%. This indicates that AXSM experiences smaller price fluctuations and is considered to be less risky than INZY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AXSM vs. INZY - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Inozyme Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities